37286511000001101: Lorlatinib (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

267651000001115 Lorlatinib en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

267661000001117 Lorlatinib (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lorlatinib	Is a	Substance with protein-tyrosine kinase inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lorlatinib 100mg tablets	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorlatinib 25mg tablets	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) 120 tablet 12 x 10 tablets	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd)	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorviqua 100mg tablets (Pfizer Ltd)	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorviqua 100mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorlatinib 100mg tablets 30 tablet	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorlatinib 25mg tablets 90 tablet	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) 90 tablet 9 x 10 tablets	Has specific active ingredient	False	Lorlatinib	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets